Soteria: Evaluation of a home-based treatment for schizophrenia.
Data are reported from an ongoing study comparing outcome in two groups of young, first-admission schizophrenics - one receiving "usual" treatment (including drugs) on the wards of a good community mental health center, the other being treated by a non-professional staff (usually without phenothiazines) in a small home-like facility in the community. Six-month and one-year outcome data show few differences in symptoms between the two groups, but three measures of psychosocial functioning significantly favor the experimental group.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003156:Community Mental Health Services; D003365:Costs and Cost Analysis; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D009788:Occupational Therapy; D010359:Patient Readmission; D011369:Professional-Patient Relations; D011577:Psychodrama; D011581:Psychological Tests; D011613:Psychotherapy; D012111:Residence Characteristics; D012114:Residential Treatment; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*; D012917:Social Adjustment; D014937:Work
D014150:Antipsychotic Agents; D002746:Chlorpromazine